Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Inspire Medical Systems, Inc.INSP · Entity 1186 | VP, Human Resources | January 30, 2024 | February 01, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Inspire Medical Systems, Inc.
Report date January 30, 2024 · Filed February 01, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 23,096 |
Reported balance
After 2024-01-30 transaction · row 1
1 source rowRow 1 · 2024-01-30 · Exercise / conversion · Acquired 16,225 · Balance 23,096 |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.94 · Expires 2027-09-25 | Direct | 3,100 |
Reported balance
After 2024-01-30 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2024-01-30 · Exercise / conversion · Disposed 16,225 · Balance 3,100 F1: The option is fully vested and exercisable. |
| Common StockSEC Table I · non-derivative | IndirectBy daughter | 478 |
Reported balance
Holding disclosure · report date 2024-01-30 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 478 |
| Common StockSEC Table I · non-derivative | IndirectBy son | 478 |
Reported balance
Holding disclosure · report date 2024-01-30 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 478 |
Filing footnotes · ownership attribution and instrument terms
F1: The option is fully vested and exercisable.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 19, 2020 Filed May 20, 2020 20:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 1,000 | $0.94 | $940.00 |
DisclosureSEC source: 0001104659-20-064260 · a4.xml · nonDerivative · entry 1 Jandrich Steven · CIK 0001737203 · Chief Comp Off & VP, Human Res 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,805 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 21, 2020 Filed Apr 23, 2020 20:31 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001104659-20-050349 · a4.xml · derivative · entry 5 Jandrich Steven · CIK 0001737203 · Chief Comp Off & VP, Human Res 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,075 Underlying: Common Stock · 2,000 shares Expires 2027-09-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is fully vested and exercisable. F4 · derivative.expiration_date: This option grant was previously reported as having an expiration date of September 24, 2027, which has been revised herein. Read SEC document |
| April 21, 2020 Filed Apr 23, 2020 20:31 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 2,000 | $72.68 | $145,360.00 |
DisclosureSEC source: 0001104659-20-050349 · a4.xml · nonDerivative · entry 2 Jandrich Steven · CIK 0001737203 · Chief Comp Off & VP, Human Res 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,805 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| April 21, 2020 Filed Apr 23, 2020 20:31 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 2,000 | $0.94 | $1,880.00 |
DisclosureSEC source: 0001104659-20-050349 · a4.xml · nonDerivative · entry 1 Jandrich Steven · CIK 0001737203 · Chief Comp Off & VP, Human Res 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,805 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 455 additional shares acquired under the Company's 2018 Employee Stock Purchase Plan since the Reporting Person's ownership report filed on December 18, 2019. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 21:42 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantEmployee Stock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $71.00 | $0.00 |
DisclosureSEC source: 0001104659-19-073830 · a4.xml · derivative · entry 1 Jandrich Steven · CIK 0001737203 · Chief Comp Off & VP, Human Res 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-12-16 F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of December 16, 2019 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| December 18, 2018 Filed Jan 4, 2019 22:18 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantEmployee Stock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $42.15 | $0.00 |
DisclosureSEC source: 0001104659-19-000852 · a4.xml · derivative · entry 1 Jandrich Steven · CIK 0001737203 · Chief Comp Off & VP, Human Res 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2028-12-18 F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of December 18, 2018 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| May 07, 2018 Filed May 10, 2018 00:41 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | PurchaseCommon Stock | 350 | $16.00 | $5,600.00 |
DisclosureSEC source: 0001104659-18-031847 · a4.xml · nonDerivative · entry 3 Jandrich Steven · CIK 0001737203 · Chief Comp Off & VP, Human Res 10b5-1 filing: Not disclosed Ownership: Indirect · By daughter Disclosed balance after: 350 Read SEC document |
| May 07, 2018 Filed May 10, 2018 00:41 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | PurchaseCommon Stock | 350 | $16.00 | $5,600.00 |
DisclosureSEC source: 0001104659-18-031847 · a4.xml · nonDerivative · entry 2 Jandrich Steven · CIK 0001737203 · Chief Comp Off & VP, Human Res 10b5-1 filing: Not disclosed Ownership: Indirect · By son Disclosed balance after: 350 Read SEC document |
| May 07, 2018 Filed May 10, 2018 00:41 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | PurchaseCommon Stock | 1,350 | $16.00 | $21,600.00 |
DisclosureSEC source: 0001104659-18-031847 · a4.xml · nonDerivative · entry 1 Jandrich Steven · CIK 0001737203 · Chief Comp Off & VP, Human Res 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,350 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.